$9.20
-0.28-2.95%
At close: -
$9.09
-0.11-1.22%
After Hours: Jan 31, 9:04 AM EDT
Comments
Loading...
Latest news for Kala Bio (NASDAQ:KALA) Stock
Kala Bio Stock (NASDAQ: KALA)
Categories: All
Friday, January 24, 2025
Friday, November 15, 2024
Monday, August 19, 2024
Tuesday, August 06, 2024
Thursday, July 25, 2024
Thursday, June 27, 2024
Friday, May 17, 2024
Tuesday, May 14, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Tuesday, December 05, 2023
Friday, November 17, 2023
Monday, November 13, 2023
Friday, August 11, 2023
Friday, August 04, 2023
Wednesday, August 02, 2023
Monday, July 24, 2023
Thursday, June 15, 2023
Friday, June 02, 2023
Monday, May 15, 2023
Wednesday, May 10, 2023
Tuesday, May 09, 2023
Monday, May 08, 2023
Monday, May 01, 2023
Monday, April 24, 2023
Monday, April 17, 2023
Wednesday, April 12, 2023
Tuesday, April 04, 2023
Monday, April 03, 2023
Monday, March 27, 2023
- 10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch
- Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nations
- HC Wainwright & Co. Reiterates Buy on Kala Ph...
- Kala Pharmaceuticals Reports Safety Update Fr...
Monday, March 20, 2023
Thursday, March 16, 2023
Monday, March 13, 2023
Wednesday, March 08, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Kala Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 17/197,702 Titled "Crystalline Forms Of Therapeutic Compounds And Uses Thereof (For Treating Diseases Such As Cancer And Macular Degeneration)"
- Peering Into Kala Pharmaceuticals's Recent Short Interest